Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing← ALL VIDEOSClinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testingNovember 16th, 2020FEATURED PRESENTERS Yury Monczak, Ph.D / Ryan J. Schmidt, MD, PhD Invivoscribe Marketing2022-05-09T03:52:41+00:00
